European Pharmacopoeia

European Pharmacopoeia
Monographs of the European Pharmacopoeia are reproduced in this edition of the British Pharmacopoeia by incorporation of the text published under the direction of the Council of Europe (Partial Agreement) in accordance with the Convention on the Elaboration of a European Pharmacopoeia (Treaty Series No. 32 (1974) CMND 5763) as amended by the Protocol to the Convention (Treaty Series No. MISC16 (1990) CMND 1133). They are included for the convenience of users of the British Pharmacopoeia. In cases of doubt or dispute reference should be made to the Council of Europe text.
Monographs of the European Pharmacopoeia are distinguished by a chaplet of stars against the title and by reference to the European Pharmacopoeia monograph number included immediately below the title in italics.The beginning and end of text from the European Pharmacopoeia are denoted by means of horizontal lines with the symbol 'Ph Eur' ranged left and right, respectively.
Inclusion of a triangle within the chaplet of stars denotes monographs that have been adopted by the European Pharmacopoeia Commission following their preparation according to a procedure of harmonisation agreed between the bodies responsible for the European Pharmacopoeia and those of Japan and the United States of America.
The general provisions of the European Pharmacopoeia relating to different types of dosage form are included in the appropriate general monograph in that section of the British Pharmacopoeia entitled Monographs: Formulated Preparations. These general provisions apply to all dosage forms of the type defined, whether an individual monograph is included in the British Pharmacopoeia or not.
Texts of the European Pharmacopoeia are governed by the General Notices of the European Pharmacopoeia. These are reproduced as Part III of these notices.